High-grade B-cell lymphoma · 2 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Pola-R-CHP Variant #01 | — | R 147 394 | 21d | — | — | 8 | R 936 175 PFS proxy | 1 |
R-CHOP Variant #08 | — | R 26 946 | 21d | — | — | ~6 | ~R 109 868 PFS proxy · indirect | 1 |
2 of 2 regimens shown